Citeline Podcasts

Scrip's Five Must-Know Things - Oct. 20, 2025

20 Oct 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended October 17, 2025. In this episode: big pharma still sees ...

Drug Fix: US FDA Involved In Astra Zeneca’s Drug Pricing Deal, DOJ’s Off-Label Promotion Policy

17 Oct 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Editor-in-Chief Nielsen Hobbs discuss the reasons US Food and Drug A...

Adalvo: Exploring European B2B Pharma’s Next Steps

17 Oct 2025

Contributed by Lukas

Adalvo: Exploring European B2B Pharma’s Next Steps by Citeline

Lupus Clinical Development Enters a New Era of Innovation

16 Oct 2025

Contributed by Lukas

Join host David Wild as he speaks with Stacie Bell, chief clinical research officer at Lupus Therapeutics, about the dramatic transformation happening...

Essential Pharma – Following A Patient First Philosophy

15 Oct 2025

Contributed by Lukas

In Vivo spoke with Emma Johnson, CEO of Essential Pharma, to discuss the company's strategic priorities and plans for growth as it expands its portfol...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)

14 Oct 2025

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年10月10日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Oct. 14, 2025

14 Oct 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended October 10, 2025. In this episode: biopharma financing re...

Cereno Scientific Turns To Old Drug For Rare Cardiopulmonary Diseases

10 Oct 2025

Contributed by Lukas

Cereno Scientific CEO Sten Sörensen discusses how his company is repurposing a 60-year-old epilepsy drug as a potential game-changer for pulmonary ar...

Defining the Next Era of Disruption

07 Oct 2025

Contributed by Lukas

Listen now as Citeline speaks with top executives from Perceptive to understand eClinical’s major reset and what it means for the future of clinical...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Oct.7, 2025

07 Oct 2025

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年10月3日当周的生物制药行业的商业动态。本期节目采用人...

Celebrating Europe’s Consumer Health Best Practice, With AESGP’s Luis Rhodes Baiao

06 Oct 2025

Contributed by Lukas

Celebrating Europe’s Consumer Health Best Practice, With AESGP’s Luis Rhodes Baiao The Association of the European Self-Care Industry, or AESGP, h...

Scrip's Five Must-Know Things - Oct. 6, 2025

06 Oct 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended October 3, 2025. In this episode: Pfizer’s backroom US ...

Drug Fix: Government Shutdown’s Impact On US FDA, Pfizer Inks Drug Pricing Deal

03 Oct 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, and senior editors Sue Sutter and Cathy Kelly consider the impact of th...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.30, 2025

30 Sep 2025

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年9月26日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - Sept. 30, 2025

30 Sep 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended September 26, 2025. In this episode: Pfizer jumps back in...

The Generics Bulletin Podcast: Talking with AAM president and CEO John Murphy

26 Sep 2025

Contributed by Lukas

Generics Bulletin editor Dave Wallace talks to John Murphy III, president and CEO of the US Association for Accessible Medicines, about the associatio...

3分で解説 #世界のファーマ】第26回 欧州の先発医薬品 米国関税15％適用へ (Japanese-language podcast) Sept.24, 2025

24 Sep 2025

Contributed by Lukas

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.22, 2025

22 Sep 2025

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年9月19日当周的生物制药行业的商业动态。本期节目采用人...

Scrip's Five Must-Know Things - September 22, 2025

22 Sep 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended September 19, 2025. In this episode: GSK announces US inv...

ICROM on Innovation in HPAPI & Crystallization

19 Sep 2025

Contributed by Lukas

Hear from ICROM CEO Pierfrancesco Morosini and HOLODIAG GM Pierric Marchand as they discuss how the company is advancing HPAPI development, solid-stat...

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Sept.16, 2025

16 Sep 2025

Contributed by Lukas

本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年9月12日当周的生物制药行业的商业动态。 本期要闻——诺...

Scrip's Five Must-Know Things - September 16, 2025

16 Sep 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended September 12, 2025. In this episode: Novo Nordisk cuts 9,...

Drug Fix: US FDA DTC Ad Crackdown Emerges From MAHA Report

12 Sep 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs look at the...

Drive Early CRO Engagement to Optimize Funding, Trial Design, and Recruitment in Biotech

12 Sep 2025

Contributed by Lukas

What makes a biotech-CRO partnership truly work? Claire Riches, VP, Clinical Solutions, Citeline, and Matt Simmons, Senior Director, Oncology Strategy...

Why Local Matters: A Leadership Perspective on Community-Based Trials

09 Sep 2025

Contributed by Lukas

Community based trials are reshaping clinical research, broadening patient access and accelerating timelines. Discover the drivers, challenges and fut...

From Abandonment To Opportunity In Pediatric Pharma

08 Sep 2025

Contributed by Lukas

In Vivo spoke with Annette Bakker, CEO of the Children’s Tumor Foundation, a medical research foundation developing an innovative approach to revivi...

Scrip's Five Must-Know Things - September 5, 2025

08 Sep 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended September 5, 2025. In this episode: the US MASH market af...

Is It Better To Be A Sustainability ‘Shaper’ Or ‘Staller’? With PA Consulting’s Rhea Patten

07 Sep 2025

Contributed by Lukas

For today’s consumers, sustainability is an expectation rather than a luxury, according to PA Consulting’s latest Brand Impact Index. In other wor...

Drug Fix: US FDA Drops Offit, Others From Adcomms, Releases Unapproved Product Rejection Letters

05 Sep 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider th...

China Biopharma English-Language Podcast: China Innovative Drugs And Commercial Insurance

02 Sep 2025

Contributed by Lukas

In this episode of the China Biopharma English-language Podcast, Shanghai-based senior reporter Xu Hu talks about the release for the first time by Ch...

Scrip's Five Must-Know Things - Sept. 1, 2025

01 Sep 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended August 29, 2025. In this episode: Lilly’s orforglipron ...

Drug Fix: US FDA Changes COVID-19 Vaccine Labeling, Reimbursement Confusion Rises

29 Aug 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Senior Editor Sue Sutter discuss the impact of US Food and Drug Admi...

Navigating What’s Next for Global Drug Development: What Sponsors Need to Know

29 Aug 2025

Contributed by Lukas

As global regulatory expectations evolve, biotech sponsors face growing pressure to make smarter, earlier decisions about where and how to run their t...

VC가 한발 물러설 때 바이오 기업의 대체 자금원은? (Korean-language podcast)

29 Aug 2025

Contributed by Lukas

전통적 벤처캐피털이 점점 더 신중하고 선별적인 투자 성향으로 변하면서 바이오 기업들이 새로운 자본 조달 경로...

【3分で解説 #世界のファーマ】第25回 中国、民間保険で新薬のアクセス拡大へ

28 Aug 2025

Contributed by Lukas

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...

How To ‘Vibe’ With Consumers, With PA Consulting’s Rhea Patten

26 Aug 2025

Contributed by Lukas

Despite the recent pressure on their finances, consumers are rejecting the idea of choosing brands based on cost alone, according to PA Consulting’s...

Scrip's Five Must-Know Things - August 25, 2025

25 Aug 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended August 22, 2025. In this episode: Madrigal regains MASH l...

Merck KGaA's Vision For Making Digital Health Redundant

22 Aug 2025

Contributed by Lukas

Merck KGaA's Emre Ozcan outlines the company's systematic approach to integrating digital solutions across the care continuum in specialty pharmaceuti...

Tevard CEO Sees Hope for HIs Daughter In His Company's tRNA Platform

18 Aug 2025

Contributed by Lukas

Tevard Biosciences CEO Daniel Fischer discusses how engineered suppressor tRNAs enable read-through of premature stop codons to restore full-length pr...

Scrip's Five Must-Know Things - August 15, 2025

18 Aug 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended August 15, 2025. In this episode: a look at the likely to...

Scrip's Five Must-Know Things - August 8, 2025

12 Aug 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended August 8, 2025. In this episode: Trump ups pressure on MF...

Turning Global Ambition Into Local Reality, With Haleon’s Jo Cooper

11 Aug 2025

Contributed by Lukas

It’s been about three years since Haleon became a standalone self-care company. Since then, the firm has announced an ambitious plan to reach one bi...

Aurigene Oncology CEO On Biotech Valuations, CAR-Ts And Reimbursement Models

05 Aug 2025

Contributed by Lukas

Dr Murali Ramachandra, CEO of Aurigene Oncology, talks to Anju Ghangurde about the tough biotech funding environment, promising pipeline assets includ...

Poolbeg CEO On The Biotech’s Big Bet On Small Molecules

04 Aug 2025

Contributed by Lukas

In the latest episode of the In Vivo Podcast, Jeremy Skillington, CEO of Poolbeg Pharma, discussed the company’s ambitious pipeline and strategic di...

Scrip's Five Must-Know Things - August 4, 2025

04 Aug 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended August 1, 2025. In this episode: EU tariff deal leaves qu...

Exploring Ex-US Markets to Reduce Risk for Your Clinical Trials

01 Aug 2025

Contributed by Lukas

Amid growing uncertainty in the U.S. regulatory landscape, sponsors are increasingly looking to ex-U.S. markets as a strategic way to reduce clinical ...

The Patient Journey: Key R&D Considerations In Rheumatoid Arthritis

29 Jul 2025

Contributed by Lukas

Listen to learn more about the evolving landscape of rheumatoid arthritis treatment through the lens of the patient experience. One RA patient shares ...

Seizing The Healthy Aging Opportunity, With Prime Fifty’s Max Gowland

29 Jul 2025

Contributed by Lukas

Healthy aging has been identified as an important trend that consumer healthcare companies need to respond to. According to founder and managing direc...

Scrip's Five Must-Know Things - July 28, 2025

28 Jul 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended July 25, 2025. In this episode: Sanofi’s Vicebio buy; S...

Drug Fix: US FDA’s New Top Drug Regulator, Sarepta’s Options After Elevidys Stand-Off

25 Jul 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith and Editor-in-Chief Nielsen Hobbs discuss the issues awaiting George Tid...

MoonLake Leaders On Its Fast-Track Vision And $500m Deal

23 Jul 2025

Contributed by Lukas

MoonLake Immunotherapeutics is racing ahead in the biotech space with its innovative nanobody SLK and a transformative $500m non-dilutive financing de...

Scrip's Five Must-Know Things - July 22, 2025

22 Jul 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended July 18, 2025. In this episode: – J&J delivers in Q2 de...

Scrip M&A Podcast: Is Biopharma M&A In A Holding Pattern Or A ‘New Normal’

21 Jul 2025

Contributed by Lukas

Scrip discusses the latest M&A activity and trends with CEO Shawn Titcomb of Allele Capital and Cheryl Reicin, a partner focused on international life...

Drug Fix: CBER Director’s Political Spin On COVID-19 Vaccines And US FDA RIFs Finalized

18 Jul 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss why ...

Strategic Insights into the RNA Market

17 Jul 2025

Contributed by Lukas

Join Meredith Landry, Managing Editor of Citeline’s Custom Content, in conversation with Tom Hickey, Director of Therapeutic Strategy at Novotech, a...

Digital Health Roundup: Autonomous Robots, Medtronic’s Surgeon School, Sleep Tech & FDA Rules

16 Jul 2025

Contributed by Lukas

In this week's Digital Health Roundup, MedTech Insight's Marion Webb discusses her interview with Johns Hopkins researcher Axel Krieger who published ...

“They Are Able To Keep Their Body”: Medipost On Its Stem Cell Therapy Vision

16 Jul 2025

Contributed by Lukas

The latest episode of the In Vivo podcast features an interview Edward Ahn, CEO of Medipost, a Korean company that has developed stem cell therapies f...

Astellas Doubles Down on Gene Therapy Despite Industry Headwinds

15 Jul 2025

Contributed by Lukas

Astellas is doubling down on gene therapy while others retreat. Richard Wilson, SVP Primary Focus Lead, Genetic Regulation at Astellas, joins In Vivo ...

Scrip's Five Must-Know Things - July 14, 2025

14 Jul 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended July 11, 2025. In this episode: Merck & Co’s Verona acq...

Seizing The GLP-1 Wellness Opportunity, With Kerry Group’s Mathieu Millette

14 Jul 2025

Contributed by Lukas

Originally developed to treat diabetes, GLP-1 agonists have been found to suppress appetite and reduce calorie intake, fueling their growing popularit...

바이오 USA: 금융 시장 스트레스, 딜메이킹 기회 창출 (Korean-language podcast)

11 Jul 2025

Contributed by Lukas

올해 제약바이오 M&A 가 다소 주춤할 것으로 전망되고 있지만, 재정난을 겪고 있는 의약품 개발업체들이 자금조달...

Phil L'Huillier, Scancell CEO, on the Latest Developments in Cancer Vaccines

09 Jul 2025

Contributed by Lukas

The latest episode of the In Vivo podcast features an interview with Phil L'Huillier, who discusses the inclusion of Scancell's melanoma cancer vaccin...

Acuitas CSO on CRISPR Delivery Breakthrough and Innovations in Lipid Nanoparticles

07 Jul 2025

Contributed by Lukas

Ying Tam, Chief Scientific Officer at Acuitas Therapeutics, discusses the company's role in delivering the first personalized CRISPR gene editing trea...

Oxolife’s Agnés Arbat, Winner Of The European Prize For Women Innovators

07 Jul 2025

Contributed by Lukas

The latest episode of the In Vivo podcast features an conversation with Agnès Arbat, CEO and co-founder of Barcelona-based biotech company OxoLife, w...

How To Balance Access And Equity In Self-Care, With Bayer’s Emese Csoke

07 Jul 2025

Contributed by Lukas

According to a recently published study by Bayer Consumer Health, being poor makes it more likely that you will suffer from self-treatable health cond...

Scrip's Five Must-Know Things - July 7, 2025

07 Jul 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended July 4, 2025. In this episode: AbbVie’s big autoimmune ...

【3分で解説 世界のファーマ】第24回 トランプ関税 製薬大国インドへの影響 (Japanese-language podcast)

03 Jul 2025

Contributed by Lukas

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...

ADDF's Karen Harris: Investing in Alzheimer's Like a VC

02 Jul 2025

Contributed by Lukas

How is venture philanthropy revolutionizing Alzheimer's drug discovery? We sit down with Karen Harris, CFO at the Alzheimer's Drug Discovery Foundatio...

China Biopharma English-Language Podcast: Obesity Drugs Not All About Weight Loss

02 Jul 2025

Contributed by Lukas

In the first episode of this new China Biopharma English-language mini podcast, Shanghai-based senior reporter Xu Hu looks at the main directions in w...

Datamonitor Healthcare Podcast: ASCO 2025

30 Jun 2025

Contributed by Lukas

Summer Colling and Emma Wille speak with oncology experts Nkiru Ibeanu, Neha Anand, Anna Simmons and David Dahan about the 2025 American Society of Cl...

Master Regulatory Hurdles and Accelerate Your Drug Development

30 Jun 2025

Contributed by Lukas

With growing FDA bottlenecks and regulatory changes, this episode explores how biotechs are looking beyond borders by rethinking trials, embracing rea...

Scrip's Five Must-Know Things - June 30, 2025

30 Jun 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended June 27, 2025. In this episode: top drugs in the first qu...

Post-BIO Podcast: Thoughts From The Frontlines

26 Jun 2025

Contributed by Lukas

Join Scrip editors Mandy Jackson and Mary Jo Laffler and Pink Sheet editor Sarah Karlin-Smith as they discuss the general mood at the recent BIO Inter...

Navigating Regulatory Uncertainty: Diversity Action Plans

24 Jun 2025

Contributed by Lukas

The FDA’s Diversity Action Plan guidance underwent several changes in recent months—with the draft guidance taken down, restored, and then pulled ...

How to Crush Competitive Threats and Stand Out in Biotech

23 Jun 2025

Contributed by Lukas

The race for new therapies is more intense than ever. This episode uncovers how biotech and pharma use competitive intelligence, AI, and data to outsm...

Scrip's Five Must-Know Things - June 23, 2025

23 Jun 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended June 20, 2025. In this episode: US policies in spotlight ...

유럽 바이오기업, 자금조달의 현주소는? (Korean-language podcast)

17 Jun 2025

Contributed by Lukas

관세와 무역 장벽의 출현, 정책 변화 등으로 올해 유럽 바이오기업들의 자금조달이 쉽지 않은 상황이라는 In Vivo 기...

Brain+ CEO Discusses “Groundbreaking” Potential Of CST Assistant For Dementia Patients

16 Jun 2025

Contributed by Lukas

Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and ...

Unpacking EU Omnibus And Its Impact On Sustainability: With CEN Group’s Jasper Crone

16 Jun 2025

Contributed by Lukas

The European Commission has put forward a series of proposals designed to simplify European Union sustainability rules and boost the region’s compet...

Scrip's Five Must-Know Things - 16 June 2025

16 Jun 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 13 June 2025. In this episode: breaking down big pharma’...

Drug Fix: The US and Ex-US Impact Of Most-Favored Nation Drug Pricing

13 Jun 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Francesca Bruce, Senior Editor Cathy Kelly and Editor-in-Chief Nielsen Hobbs consider Europ...

Citeline Japan Awards 2025 - Entry Deadline Approaching! (Bilingual English/Japanese)

12 Jun 2025

Contributed by Lukas

The 14 July entry deadline for the Citeline Japan Awards 2025 in Tokyo on 21 October is fast approaching! Join Ian Haydock and Lisa Takagi in this bil...

Strategies to Secure Critical Biotech Funding Amid Market Challenges

11 Jun 2025

Contributed by Lukas

Biotechs are racing to change the rules in this tough market. This episode reveals how AI, real-world data, and strategic partnerships are reshaping d...

How to Survive Innovation Pressure in Today’s Biotech Landscape

11 Jun 2025

Contributed by Lukas

Small biotech companies are facing tough times, shrinking funding and uncertain futures. But beneath the surface, quiet forces of innovation and resil...

Scrip's Five Must-Know Things - 9 June 2025

09 Jun 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 6 June 2025. In this episode: Sanofi’s Blueprint buy; A...

Drug Fix: Prasad Staying Out Of Application Reviews, US FDA Proposed Budget Cuts

06 Jun 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs discuss why ...

A Deep Dive into Sjögren's Disease

06 Jun 2025

Contributed by Lukas

Summer Colling speaks with Emma Wille about the symptoms, diagnosis, and treatment landscape of Sjögren’s disease, highlighting the latest research...

Digital Health Roundup: Synchron Syncs With Apple, Ketryx’s AI Agents, AdvaMed’s AI RoadMap

04 Jun 2025

Contributed by Lukas

In this week's Digital Health Roundup, MedTech Insight's Shubham Singh explores how Ketryx's launch of validated AI agents could reshape compliance au...

Raj Panjabi on Flagship's Preemptive Health and Medicine Initiative

03 Jun 2025

Contributed by Lukas

Flagship Pioneering senior partner Raj Panjabi discusses shifting healthcare from reactive treatment to AI-powered prediction and prevention of diseas...

SGLT2 Inhibitors Cardiovascular and Safety Outcomes in Chronic Diseases

03 Jun 2025

Contributed by Lukas

SGLT2 Inhibitors Cardiovascular and Safety Outcomes in Chronic Diseases by Citeline

Plant-Based Diet Improves Outcomes in Metastatic Breast Cancer

03 Jun 2025

Contributed by Lukas

Plant-Based Diet Improves Outcomes in Metastatic Breast Cancer by Citeline

The Generics Bulletin Podcast: The Global Generics & Biosimilars Awards 2025

03 Jun 2025

Contributed by Lukas

Generics Bulletin editors Dave Wallace and Dean Rudge discuss the Global Generics & Biosimilars Awards 2025, providing all the key details of the even...

Podcast: Navigating the Future of Hepatology Clinical Trials

02 Jun 2025

Contributed by Lukas

Join Andrew Warmington, Manufacturing Editor at Citeline, in conversation with Tom Hickey, Director of Therapeutic Strategy at Novotech, a global full...

Innovation & Integrity: The Dual Path to Success for Device Makers

02 Jun 2025

Contributed by Lukas

An expert from ISACA shares her insights into medtech’s Voluntary Improvement Program (VIP), a collaboration among participants, ISACA, MDIC, and US...

Driving Innovation And Growth In France’s Self-Care Market, With Neres Luc Besançon

02 Jun 2025

Contributed by Lukas

Largely driven by community pharmacy footfall, France’s self-care market is dynamic and characterized by high levels of innovation, according to Fre...

Scrip's Five Must-Know Things - 2 June 2025

02 Jun 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 30 May 2025. In this episode: a preview of major ASCO rea...

Drug Fix: US FDA’s Private Pharma CEO Tour, HHS Changes COVID-19 Vaccine Recommendation

30 May 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider the...

FDA in Transition: How Regulatory Shifts Are Redefining Drug Development

27 May 2025

Contributed by Lukas

The uncertainty surrounding changes at the FDA and other market dynamics is reshaping the global drug development landscape. In this webinar, CRO regu...

Scrip's Five Must-Know Things - 26 May 2025

26 May 2025

Contributed by Lukas

Audio roundup of selected biopharma industry content from Scrip over the business week ended 23 May 2025. In this episode: Novo Nordisk’s CEO forced...

Drug Fix: US FDA’s Big Vaccine Policy Week

23 May 2025

Contributed by Lukas

Pink Sheet Executive Editor Derrick Gingery, Senior Writer Sarah Karlin-Smith, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consider the...